David Solomon

61PUBLICATIONS
162CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Feb 06, 2026
A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma.

Jiaying Chen, Nancy Ann Oberheim Bush, Jennifer A Grabowsky

|Mar 07, 2025
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.

Eduardo Rodriguez Almaraz, Geno A Guerra, Nadeem N Al-Adli

|Nov 19, 2024
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.

Calixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young

|Nov 13, 2024
Identification of genomic biomarkers of disease progression and survival in primary CNS lymphoma.

Huimin Geng, Shirley Mo, Lingjing Chen

|May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution.

Calixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo

|Dec 11, 2023
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.

Sara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush

Pageof 11

Frequent Collaborators

13 joint publications

Arie Perry

9 joint publications

Joanna Phillips

8 joint publications

David Raleigh

8 joint publications

Calixto-Hope Lucas